Neogenomics Inc
NEO· Nasdaq
Filed May 11, 2015 · 10-Q · 41 days after period end · 0001193125-15-181991
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$761.00K | $102.00K | $3.00K | $603.00K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end